Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

OMKAR PHARMACHEM vs ACTAVIS (US) - Comparison Results

ACTAVIS (US)
   Change

Actavis, Inc. is a global, integrated specialty pharmaceutical company focused on developing, manufacturing and distributing generic, brand and biosimilar products. It develops, manufactures and market generic, branded generic, legacy brands and Over... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 OMKAR PHARMACHEM   ACTAVIS
EQUITY SHARE DATA
    OMKAR PHARMACHEM
Mar-23
ACTAVIS
Dec-18
OMKAR PHARMACHEM/
ACTAVIS
5-Yr Chart
Click to enlarge
High Rs2516,134-   
Low Rs1910,823-   
Sales per share (Unadj.) Rs0.53,957.7-  
Earnings per share (Unadj.) Rs0.2-1,274.8-  
Cash flow per share (Unadj.) Rs0.2417.1-  
Dividends per share (Unadj.) Rs00-  
Avg Dividend yield %00-  
Book value per share (Unadj.) Rs9.016,323.5-  
Shares outstanding (eoy) m10.08332.60-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x41.43.4 1,216.0%   
Avg P/E ratio x113.1-10.6 -1,069.6%  
P/CF ratio (eoy) x111.532.3 345.1%  
Price / Book Value ratio x2.50.8 299.5%  
Dividend payout %00-   
Avg Mkt Cap Rs m2244,482,908 0.0%   
No. of employees `000NA16.9 0.0%   
Total wages/salary Rs m10-   
Avg. sales/employee Rs Th077,888.8-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th0-25,088.0-  
INCOME DATA
Net Sales Rs m51,316,320 0.0%  
Other income Rs m025,172 0.0%   
Total revenues Rs m51,341,492 0.0%   
Gross profit Rs m334,494 0.0%  
Depreciation Rs m0562,698 0.0%   
Interest Rs m075,959 0.0%   
Profit before tax Rs m3-578,991 -0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0147,666 0.0%   
Tax Rs m1-7,337 -0.0%   
Profit after tax Rs m2-423,987 -0.0%  
Gross profit margin %57.62.6 2,197.8%  
Effective tax rate %25.21.3 1,986.1%   
Net profit margin %36.6-32.2 -113.7%  
BALANCE SHEET DATA
Current assets Rs m3539,886 0.0%   
Current liabilities Rs m7477,601 0.0%   
Net working cap to sales %-78.54.7 -1,659.4%  
Current ratio x0.41.1 33.8%  
Inventory Days Days6,28620 32,100.0%  
Debtors Days Days87666 1,321.1%  
Net fixed assets Rs m93149,000 0.1%   
Share capital Rs m1010-   
"Free" reserves Rs m-100-   
Net worth Rs m905,429,205 0.0%   
Long term debt Rs m01,911,820 0.0%   
Total assets Rs m968,487,083 0.0%  
Interest coverage x6.6-6.6 -99.9%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.10.2 36.4%   
Return on assets %2.6-4.1 -62.4%  
Return on equity %2.2-7.8 -28.0%  
Return on capital %3.4-4.8 -71.1%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m00-   
CASH FLOW
From Operations Rs m3470,272 0.0%  
From Investments Rs mNA258,353 0.0%  
From Financial Activity Rs m-4-807,127 0.0%  
Net Cashflow Rs m-1-78,110 0.0%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ACTAVIS (US) is United States Dollars. All data has been converted at 83.38 Rs / USD

Compare OMKAR PHARMACHEM With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  

Compare OMKAR PHARMACHEM With: AARTI PHARMALABS  UNICHEM LAB  ROOPA INDUSTRIES  ZANDU REALTY  ZYDUS LIFESCIENCES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.